Group One Trading, L.P. Enochian Biosciences Inc Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.4 - $1.3 $27 - $88	-68 Reduced 98.55%	1 $0
Q1 2023 May 12, 2023	BUY	$0.91 - $1.31 $62 - $90	69 New	69 $0
Q2 2022 Aug 11, 2022	BUY	$1.93 - $8.73 $5,950 - $26,914	3,083 New	3,083 $6,000
Q1 2022 May 12, 2022	SELL	$4.42 - $9.0 $8,455 - $17,217	-1,913 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.71 - $12.55 $3,697 - $6,915	551 Added 40.46%	1,913 $14,000
Q3 2021 Nov 12, 2021	BUY	$4.56 - $7.88 $6,210 - $10,732	1,362 New	1,362 $9,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.